Whitehawk Therapeutics (WHWK) Return on Sales (2018 - 2025)

Whitehawk Therapeutics (WHWK) has 7 years of Return on Sales data on file, last reported at 0.13% in Q4 2025.

• Quarterly Return on Sales rose 15.0% year-over-year to 0.13% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.13% (up 15.0% YoY) and the FY2025 annual result came in at 0.03%, changed 0.0% from the prior year.
• Return on Sales advanced to 0.13% in Q4 2025 per WHWK's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Sales topped out at 0.13% in Q4 2025 and bottomed at 0.46% in Q1 2021.
• The 5-year median for Return on Sales is 0.03% (2023), against an average of 0.04%.
• Peak annual rise in Return on Sales reached 40 bps in 2022, while the deepest fall reached 5 bps in 2022.
• Tracing WHWK's Return on Sales over 5 years: stood at 0.01% in 2021, then plunged by 133 bps to 0.03% in 2022, then climbed by 3 bps to 0.03% in 2023, then climbed by 2 bps to 0.03% in 2024, then surged by 595 bps to 0.13% in 2025.
• Per Business Quant, the three latest WHWK Return on Sales figures stand at 0.13% (Q4 2025), 0.01% (Q3 2025), and 0.0% (Q2 2025).

Peer Comparison